Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Sep;30(9):862–867. doi: 10.1136/jcp.30.9.862

IgG myeloma presenting as ulcerative colitis.

M R Haeney, I N Ross, R A Thompson, P Asquith
PMCID: PMC476577  PMID: 915014

Abstract

Two patients who presented with ulcerative colitis are described. Both were found to have evidence of IgG monoclonal gammopathy and Bence-Jones proteinuria. This association has been reported previously only in the presence of myelomatous infiltration of the gastrointestinal tract or in amyloidosis, and hence the cases reported appear to be unique.

Full text

PDF
862

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson U., Hällén J. A population study on monoclonal gammapathy. Follow-up after 5 and one-half years on 64 subjects detected by electrophoresis of 6995 sera. Acta Med Scand. 1972 Jan-Feb;191(1-2):111–113. [PubMed] [Google Scholar]
  2. BERNSTEIN J. S., NIXON D. D. ULCERATIVE COLITIS DISGUISED AS MULTIPLE MYELOMA. Am J Dig Dis. 1964 Sep;9:625–633. doi: 10.1007/BF02232121. [DOI] [PubMed] [Google Scholar]
  3. CAMPBELL A. M., HALFORD M. E. SYNDROME OF DIARRHOEA AND PERIPHERAL NERVE CHANGES DUE TO GENERALIZED VASCULAR DISEASE. Br Med J. 1964 Dec 12;2(5423):1509–1510. doi: 10.1136/bmj.2.5423.1502-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CORNES J. S., SMITH J. C., SOUTHWOOD W. F. Lymphosarcoma in chronic ulcerative colitis with report of two cases. Br J Surg. 1961 Jul;49:50–53. doi: 10.1002/bjs.18004921311. [DOI] [PubMed] [Google Scholar]
  5. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  6. FADEM R. S. Differentiation of plasmocytic responses from myelomatous diseases on the basis of bone-marrow findings. Cancer. 1952 Jan;5(1):128–137. doi: 10.1002/1097-0142(195201)5:1<128::aid-cncr2820050117>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  7. Galton D. A., Peto R. A progress report on the Medical Research Council's therapeutic trial in myelomatosis. Br J Haematol. 1968 Sep;15(3):319–320. [PubMed] [Google Scholar]
  8. Goldstein W. B., Poker N. Multiple myeloma involving the gastrointestinal tract. Gastroenterology. 1966 Jul;51(1):87–93. [PubMed] [Google Scholar]
  9. Hobbs J. R., Carter P. M., Cooke K. B., Foster M., Oon C. J. IgM paraproteins. J Clin Pathol Suppl (Assoc Clin Pathol) 1975;6:54–64. doi: 10.1136/jcp.s1-6.1.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hobbs J. R. Immunocytoma o' mice an' men. Br Med J. 1971 Apr 10;2(5753):67–72. doi: 10.1136/bmj.2.5753.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hobbs J. R. Paraproteins, benign or malignant? Br Med J. 1967 Sep 16;3(5567):699–704. doi: 10.1136/bmj.3.5567.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kohn J. Benign paraproteinaemias. J Clin Pathol Suppl (Assoc Clin Pathol) 1975;6:77–82. doi: 10.1136/jcp.s1-6.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Michaux J. L., Heremans J. F. Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Am J Med. 1969 Apr;46(4):562–579. doi: 10.1016/0002-9343(69)90075-8. [DOI] [PubMed] [Google Scholar]
  14. Myerson P., Myerson D., Miller D., DeLuca V. A., Jr, Lawson J. P. Lymphosarcoma of the bowel masquerading as ulcerative colitis: report of a case. Dis Colon Rectum. 1974 Sep-Oct;17(5):710–715. doi: 10.1007/BF02587127. [DOI] [PubMed] [Google Scholar]
  15. OSSERMAN E. F. Plasma-cell myeloma. II. Clinical aspects. N Engl J Med. 1959 Nov 5;261:952–cont'd. doi: 10.1056/NEJM195911052611906. [DOI] [PubMed] [Google Scholar]
  16. OWEN J. A., PITNEY W. R., O'DEA J. F. "Myeloma" serum electrophoretic patterns in conditions other than myelomatosis. J Clin Pathol. 1959 Jul;12:344–350. doi: 10.1136/jcp.12.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. PROLLA J. C., KIRSNER J. B. THE GASTROINTESTINAL LESIONS AND COMPLICATIONS OF THE LEUKEMIAS. Ann Intern Med. 1964 Dec;61:1084–1103. doi: 10.7326/0003-4819-61-6-1084. [DOI] [PubMed] [Google Scholar]
  18. Pruzanski W. Clinical manifestations of multiple myeloma: relation to class and type M component. Can Med Assoc J. 1976 May 22;114(10):896–897. [PMC free article] [PubMed] [Google Scholar]
  19. Talerman A., Haije W. G. The frequency of M-components in sera of patients with solid malignant neoplasms. Br J Cancer. 1973 Apr;27(4):276–282. doi: 10.1038/bjc.1973.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tangun Y., Saracbasi Z., Inceman S., Danon F., Seligmann M. Letter: IgA myeloma globulin and Bence Jones proteinuria in diffuse plasmacytoma of small intestine. Ann Intern Med. 1975 Nov;83(5):673–673. doi: 10.7326/0003-4819-83-5-673_1. [DOI] [PubMed] [Google Scholar]
  21. Williams R. C., Jr, Bailly R. C., Howe R. B. Studies of "benign" serum M-components. Am J Med Sci. 1969 May;257(5):275–293. doi: 10.1097/00000441-196905000-00001. [DOI] [PubMed] [Google Scholar]
  22. Zawadzki Z. A., Edwards G. A. Nonmyelomatous monoclonal immunoglobulinemia. Prog Clin Immunol. 1972;1:105–156. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES